INSIGHTS ON DRUG DEVELOPMENT
-
Target Product Profile (TPP) Explained
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
-
Efficiently Optimize Your Workflow With Single-Use Chromatography
Explore how low-volume purification can be done more efficiently in GMP settings with a live system demo and customer insights on optimizing workflows with single-use chromatography.
-
Multiplex Imaging
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Seed Train Intensification Using High Cell Density Cryopreservation
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit4/4/2025
Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.
-
Advantages Of Spray-Dried Mannitol In Roll Compaction4/2/2025
Pharmaceutical excipients like mannitol enhance formulation stability, flowability, and compressibility, which are crucial for robust tablets. Read how these properties improve patient compliance.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
DRUG DEVELOPMENT SOLUTIONS
-
We offer a comprehensive method optimization service to take early stage development methods with poor stability indication, excessive run time lengths, or legacy column chemistries and modify them.
-
High-intensity sweeteners can improve palatability across oral dosage forms. Learn more about taste-masking performance, sweetness potency, and solubility to make a more informed excipient selection.
-
DSC and ITC offer deep insights into molecular binding and structural stability, which help researchers uncover thermodynamic drivers and domain-level behavior essential for protein characterization.
-
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.